[Trovafloxacin]

Rev Med Univ Navarra. 1999 Jan-Mar;43(1):45-57.
[Article in Spanish]
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Anti-Infective Agents* / adverse effects
  • Anti-Infective Agents* / classification
  • Anti-Infective Agents* / economics
  • Anti-Infective Agents* / pharmacokinetics
  • Anti-Infective Agents* / therapeutic use
  • Drug Costs
  • Drug Evaluation
  • Drug Interactions
  • Drug Resistance, Microbial
  • Fluoroquinolones*
  • Gram-Negative Aerobic Bacteria / drug effects
  • Gram-Negative Anaerobic Bacteria / drug effects
  • Gram-Positive Bacteria / drug effects
  • Humans
  • Molecular Structure
  • Naphthyridines* / adverse effects
  • Naphthyridines* / economics
  • Naphthyridines* / pharmacokinetics
  • Naphthyridines* / therapeutic use
  • Respiratory Tract Infections / drug therapy

Substances

  • Anti-Infective Agents
  • Fluoroquinolones
  • Naphthyridines
  • trovafloxacin